<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/ED6A6B32-663C-4A62-A33B-2C6A68E2E102"><gtr:id>ED6A6B32-663C-4A62-A33B-2C6A68E2E102</gtr:id><gtr:name>University of Essex</gtr:name><gtr:department>Biological Sciences</gtr:department><gtr:address><gtr:line1>Wivenhoe Park</gtr:line1><gtr:line4>Colchester</gtr:line4><gtr:line5>Essex</gtr:line5><gtr:postCode>CO4 3SQ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/ED6A6B32-663C-4A62-A33B-2C6A68E2E102"><gtr:id>ED6A6B32-663C-4A62-A33B-2C6A68E2E102</gtr:id><gtr:name>University of Essex</gtr:name><gtr:address><gtr:line1>Wivenhoe Park</gtr:line1><gtr:line4>Colchester</gtr:line4><gtr:line5>Essex</gtr:line5><gtr:postCode>CO4 3SQ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F1E4C1EE-5494-43C0-95B1-0FB357F811CE"><gtr:id>F1E4C1EE-5494-43C0-95B1-0FB357F811CE</gtr:id><gtr:firstName>Elena</gtr:firstName><gtr:surname>Klenova</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0401088"><gtr:id>7B8B8292-C679-456B-AC80-8EEBF9A74392</gtr:id><gtr:title>Role of poly(ADP-ribosyl)ation in epigenetic control</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401088</gtr:grantReference><gtr:abstractText>The eukaryotic genome contains two categories of information: genetic and epigenetic. While the genetic information (DNA sequence) provides the blueprint for the production of components creating a living cell, the epigenetic information layered upon it dictates how, when and where the genetic information should be expressed in developing organisms. Chromatin insulators are specialized DNA elements that lie in the heart of epigenetic regulation. Insulators set up boundaries between the genes on the chromosomes and are believed to act as a neutral barrier to prevent interfering influences from the neighbouring genes. Despite the emerging realization that chromatin insulators are important regulators of expression domains and networks, very little is known about the molecular mechanisms underlying their function. Our recent observations suggest, that the process of poly(ADP-ribosyl)ation, or generation of modifying groups of an ADP-ribose polymer on proteins, could be one of the possible mechanisms regulating the function of insulators. We have demonstrated that one of the proteins, called CTCF, which is involved in the regulation of insulators, can also be modified by poly(ADP-ribosyl)ation. The main aim of the proposed study is to investigate these findings further by providing biochemical and functional data demonstrating how poly(ADP-ribosyl)ation can control vertebrate insulators via CTCF or also perhaps other proteins. As studies of the mechanisms of chromatin insulation are directly relevant to an understanding of mechanisms of regulation of gene expression, the proposed project will also lead to better understanding of many human genetic disorders, including cancer. The results of the work will be disseminated through usual routes (journal and conference publications). In addition, regular meetings are held together with the Essex Rivers NHS Trust to disseminate the results across a broad group of clinicians. My undergraduate and post-graduate academic teaching responsibilities also present an ideal opportunity to communicate the information across the Department and wider. Open Days and Science Days that are regularly held in the University provide another chance to disseminate my science to the younger audience (School children, college students etc). I also have good working relation with the local press (Evening Gazette, Colchester and Wywern, University of Essex) which cover our scientific findings, achievements and events. I also have written several popular science articles to publicize my research. Over the years I have given a number of external lectures to various audiences (general, medical, industrial etc) and am committed to communicating my science to the public in the future.</gtr:abstractText><gtr:technicalSummary>Epigenetic modifications are reversible alterations in gene expression that occur without permanent changes in DNA sequence. Recent findings demonstrate that specialized DNA elements, termed insulators, play an important role in the establishment of epigenetic marks. Chromatin insulators set up boundaries that antagonize enhancer-promoter communications in a position-dependent manner. In vertebrates, this feature involves the 11 zinc finger protein CTCF as a common denominator. Although a growing body of evidence shows that chromatin insulators are important regulators of expression domains and networks, very little is known about the molecular mechanisms underlying insulator action. Our recent findings documented the genome-wide link between insulation/imprinting and poly-ADP(ribosyl)ation, pointing to CTCF as a target for poly-ADP( ribosyl)ation. (Yu et al, 2004, Nature Genetics, in press). The main goal of the proposed project is to gain further insight into molecular mechanisms of the regulation of insulators by poly-ADP(ribosyl)ation. To achieve this goal we propose to investigate the following objectives:(i) Perform a detailed analysis of biochemical properties of the poly-ADP( ribosyl)ated form of CTCF; (ii) Undertake functional tests to study the role of poly-ADP( ribosyl)ation of CTCF in the control of the beta-globin insulator and the chromatin insulator at the H19 imprinting control region; (iii) Investigate whether there are any other poly-(ADP ribosyl)ated candidate proteins participating in the control of the insulator at the H19 imprinting control region and also identify any additional associated proteins. 
Biochemical techniques such as assays of poly-(ADP-ribose) polymerase, polymer analysis, protein chromatograpy, Western blotting and electrophoresis (one and two-dimensional) will be used in combination with various cell/tissue culture methods. Confocal microscopy will be important to monitor expression and localization of proteins, and flow cytometry will be used for an insulator assay. This project will also involve analysis of proteins by mass-spectromety.
The knowledge, technology and materials generated during this study will be made avaliable to reserchers in the UK and overseas with interests in genetic and epigenetic regulation. We expect that at the later stage private companies and government agencies are very likely to benefit from this study.</gtr:technicalSummary><gtr:fund><gtr:end>2008-10-02</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-03</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>217053</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Generation of a new isogenic insulator reporter cell line, B4.</gtr:description><gtr:id>3B29676C-D5EA-4071-93A8-9C3CFF420BD5</gtr:id><gtr:impact>This resulted in a research publication by Farrar et al 2009, MCB, in press</gtr:impact><gtr:partnerContribution>Advancing research, generation new data and publications</gtr:partnerContribution><gtr:piContribution>Generation of new data and publications</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press releases</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>88F1D72B-7773-46F7-BE30-F24CD23125B4</gtr:id><gtr:impact>Several press releases and articles describing the research were published locally, nationally and internationally. Interviews were given to the local radio.

These activities generated interest form local schools and more students then before asked to do work experience in the Department of Biological sciences.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit/work experience</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>A0A6B9B8-4321-4A63-8A9A-003763EF8CC7</gtr:id><gtr:impact>Work experience by local school children

Research was explained to the work experience students in lay men terms</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open days</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CCD7526C-46ED-43A0-83FF-0B7920E866B7</gtr:id><gtr:impact>50 pupils attended the talk, there were questions afterwards.

Pupils asked for more information about the University and the School</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>204427</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>&amp;quot;project grant&amp;quot;</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>1CAF1865-72F1-46EA-BCBD-C9C567986FDF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>204427</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research grant</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>DD324BD0-31AA-486B-9FA4-D8CFECBB23D6</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The mutated forms of CTCF deficient for poly(ADP-ribosyl)ation 9 an important post-translational modification)</gtr:description><gtr:id>3761AD45-B469-4F8D-A437-A5BF7D6CC011</gtr:id><gtr:impact>The paper by Farrar et al in MCB describing the mutants and testing them functionally is currently in press. These CTCF mutants are currently being used in several ongoing collaborative projects.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mutants of CTCF deficient for poly(ADP-ribosyl)ation</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a cell line which allows to quickly monitor the effects of exogenous and endogenous stimuli on the imprinted gene, IGF2.</gtr:description><gtr:id>448357F4-518F-421E-829E-D2138ADD48F4</gtr:id><gtr:impact>This cell line was used in the investigation currently in press ( Ref: Farrar et al 2009, MCB)</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>A new isogenic insulator reporter cell line, B4.</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06A995BD-634C-4B66-8F2F-6DBF3DF10CE5"><gtr:id>06A995BD-634C-4B66-8F2F-6DBF3DF10CE5</gtr:id><gtr:title>A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c18845fde84c2e114c25b38140bd72c"><gtr:id>8c18845fde84c2e114c25b38140bd72c</gtr:id><gtr:otherNames>Hancock AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/62BDBE73-D12D-4B5D-BA85-5CB008C35254"><gtr:id>62BDBE73-D12D-4B5D-BA85-5CB008C35254</gtr:id><gtr:title>Does CTCF mediate between nuclear organization and gene expression?</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0c14dcdde0116f727d5092f7dd8ff40"><gtr:id>a0c14dcdde0116f727d5092f7dd8ff40</gtr:id><gtr:otherNames>Ohlsson R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/237D593C-1F08-457F-BEE3-A4D9ECBB2D30"><gtr:id>237D593C-1F08-457F-BEE3-A4D9ECBB2D30</gtr:id><gtr:title>Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/99a230ccbe492aea8059d5df8b033aba"><gtr:id>99a230ccbe492aea8059d5df8b033aba</gtr:id><gtr:otherNames>Roberts J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FBE75B9-5D0E-4CA3-AE9A-238DAC6B9008"><gtr:id>7FBE75B9-5D0E-4CA3-AE9A-238DAC6B9008</gtr:id><gtr:title>Decreased poly(ADP-ribosyl)ation of CTCF, a transcription factor, is associated with breast cancer phenotype and cell proliferation.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c3e19098ab735616179f7916d11cf39"><gtr:id>6c3e19098ab735616179f7916d11cf39</gtr:id><gtr:otherNames>Docquier F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30B6F270-D313-4089-AA3E-0CE52C478911"><gtr:id>30B6F270-D313-4089-AA3E-0CE52C478911</gtr:id><gtr:title>Generation of poly(ADP-ribosyl)ation deficient mutants of the transcription factor, CTCF.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4f748485e1b6d187604ff7872d9b3aae"><gtr:id>4f748485e1b6d187604ff7872d9b3aae</gtr:id><gtr:otherNames>Farrar D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CF7118C9-6159-4554-A009-BE76A34A9B70"><gtr:id>CF7118C9-6159-4554-A009-BE76A34A9B70</gtr:id><gtr:title>BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/88a6694b7b45edcc6102f31e7c70af3f"><gtr:id>88a6694b7b45edcc6102f31e7c70af3f</gtr:id><gtr:otherNames>D'Arcy V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74EA71B5-4520-4722-A2BA-FB62D71C3D8F"><gtr:id>74EA71B5-4520-4722-A2BA-FB62D71C3D8F</gtr:id><gtr:title>Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/64923cae2c072a74b56d91891a70964b"><gtr:id>64923cae2c072a74b56d91891a70964b</gtr:id><gtr:otherNames>Ito Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC5A5566-B698-4A71-BD6E-31824B810E21"><gtr:id>FC5A5566-B698-4A71-BD6E-31824B810E21</gtr:id><gtr:title>BioVyon Protein A, an alternative solid-phase affinity matrix for chromatin immunoprecipitation.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/83a431c6fc39324b7380625e8db79491"><gtr:id>83a431c6fc39324b7380625e8db79491</gtr:id><gtr:otherNames>Chernukhin I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B4E13581-C0D4-40D9-AFBC-B2AD86D904D3"><gtr:id>B4E13581-C0D4-40D9-AFBC-B2AD86D904D3</gtr:id><gtr:title>The potential of BORIS detected in the leukocytes of breast cancer patients as an early marker of tumorigenesis.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/88a6694b7b45edcc6102f31e7c70af3f"><gtr:id>88a6694b7b45edcc6102f31e7c70af3f</gtr:id><gtr:otherNames>D'Arcy V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63C26EE0-7BD6-4733-A4CA-64605971EF77"><gtr:id>63C26EE0-7BD6-4733-A4CA-64605971EF77</gtr:id><gtr:title>Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4f748485e1b6d187604ff7872d9b3aae"><gtr:id>4f748485e1b6d187604ff7872d9b3aae</gtr:id><gtr:otherNames>Farrar D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5EF49A43-EF85-4B0F-881F-70DD5FAD1AC8"><gtr:id>5EF49A43-EF85-4B0F-881F-70DD5FAD1AC8</gtr:id><gtr:title>ADP-ribose polymer depletion leads to nuclear Ctcf re-localization and chromatin rearrangement(1).</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9e76a5ac507ca5125e73d1078aa94fb8"><gtr:id>9e76a5ac507ca5125e73d1078aa94fb8</gtr:id><gtr:otherNames>Guastafierro T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FFC5AFE3-F011-4EE9-A6AB-0EB216C954BF"><gtr:id>FFC5AFE3-F011-4EE9-A6AB-0EB216C954BF</gtr:id><gtr:title>CTCF interacts with and recruits the largest subunit of RNA polymerase II to CTCF target sites genome-wide.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/83a431c6fc39324b7380625e8db79491"><gtr:id>83a431c6fc39324b7380625e8db79491</gtr:id><gtr:otherNames>Chernukhin I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9AC1C2CD-ADD9-4B22-9AEC-896B4F5A0C2F"><gtr:id>9AC1C2CD-ADD9-4B22-9AEC-896B4F5A0C2F</gtr:id><gtr:title>Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa282898cbf0ed8a4679b0bacbd4824a"><gtr:id>aa282898cbf0ed8a4679b0bacbd4824a</gtr:id><gtr:otherNames>Ali FR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401088</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>